Content about Epinephrine autoinjector

December 18, 2013

Four school districts have won a competition sponsored by Mylan to raise awareness about dangerous allergic reactions, the company said.

PITTSBURGH — Four school districts have won a competition sponsored by Mylan to raise awareness about dangerous allergic reactions, the company said Wednesday.

Mylan, whose Mylan Specialty division makes the EpiPen injector pen for severe allergic reactions, known as anaphylaxis, announced the winners of the Raise Your Hand for Anaphylaxis Awareness competition, for which it hired actress Julie Bowen as a celebrity spokeswoman.

November 14, 2013

New legislation signed into law Wednesday encourages states to adopt laws allowing schools to maintain a supply of emergency treatments for life-threatening allergy attacks.

NEW YORK — New legislation signed into law Wednesday encourages states to adopt laws allowing schools to maintain a supply of emergency treatments for life-threatening allergy attacks.

Barack Obama signed the School Access to Emergency Epinephrine Act, under which schools could maintain a supply of epinephrine, which is the only first-line treatment for life-threatening allergic reactions, also known as anaphylaxis.

The legislation received praise from Mylan, a drug maker that produces EpiPen, a popular epinephrine injector pen.

August 20, 2013

A majority of respondents to a survey commissioned by drug maker Sanofi say that they or their children experienced a severe allergic reaction while traveling.

BRIDGEWATER, N.J. — A majority of respondents to a survey commissioned by drug maker Sanofi say that they or their children experienced a severe allergic reaction while traveling.

August 14, 2013

In its first year, more than 20,000 schools across all 50 states participated in the program that offers four free EpiPen or EpiPen Jr (epinephrine) Auto-Injectors to qualifying schools in the United States.

BASKING RIDGE, N.J. — Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan, today announced a second year of its EpiPen4Schools program. In its first year, more than 20,000 schools across all 50 states participated in the program that offers four free EpiPen or EpiPen Jr (epinephrine) Auto-Injectors to qualifying schools in the United States. Qualifications include having a valid prescription.

June 19, 2013

Target Corp. is reaching out to Canadian customers preparing to send their children to summer camp with information and resources about allergies.

MISSISSAUGA, Ontario — Target Corp. is reaching out to Canadian customers preparing to send their children to summer camp with information and resources about allergies.

The mass merchandise retailer, which has lately made a major push into Canada with 48 stores around the country, said its pharmacists would be available to provide advice on allergies.

June 18, 2013

A division of Mylan is hiring NFL player Adrian Peterson and family expert Jo Frost to promote an emergency treatment for severe allergic reactions.

BASKING RIDGE, N.J. — A division of Mylan is hiring NFL player Adrian Peterson and celebrity nanny Jo Frost to promote an emergency treatment for severe allergic reactions.

Mylan Specialty announced that it had hired the two — who both have potentially life-threatening allergies — to raise awareness of the problem. Mylan Specialty is launching a multichannel marketing campaign for the EpiPen (epinephrine) auto-injector to mark the 25th anniversary of its approval by the Food and Drug Administration.

May 29, 2013

Mylan Specialty is extending a marketing campaign around its line of emergency treatments for severe allergic reactions.

BASKING RIDGE, N.J. — Mylan Specialty is extending a marketing campaign around its line of emergency treatments for severe allergic reactions.

April 25, 2013

Mylan Specialty announced Thursday the introduction of a "$0 Co-Pay Offer" on a product used to treat severe allergic reactions.

BASKING RIDGE, N.J. — Mylan Specialty announced Thursday the introduction of a "$0 Co-Pay Offer" on a product used to treat severe allergic reactions.

The drug maker is offering a co-pay card to patients with or without insurance for the EpiPen in recognition of the 25th anniversary of its approval by the Food and Drug Administration. The co-pay card is available online at EpiPen.com, and the offer will expire on Dec. 31.

April 22, 2013

Allermates today announced it is introducing EpiPen, Auvi-Q and asthma inhaler carrying cases.

NANUET, N.Y. — Allermates today announced it is introducing EpiPen, Auvi-Q and asthma inhaler carrying cases.

The cases come in colorful kid-friendly designs and include AllerMates characters. Each case comes with an emergency contact and medication information card. The EpiPen carrying case is insulated, and comes with an epinephrine auto-injector user guide. The cases, like all AllerMates products, are nickel-, lead-, latex-, BPA- and phthalate-free.

February 25, 2013

It's another innovative, yet simple, "Made by Mom" product in the pediatric section. Iris Shamus, the mom and entrepreneur behind AllerMates, developed a line of fun characters that kids won't have a problem wearing and will alert caregivers to specific food allergies.

It's another innovative, yet simple, "Made by Mom" product in the pediatric section. Iris Shamus, the mom and entrepreneur behind AllerMates, developed a line of fun characters that kids won't have a problem wearing and will alert caregivers to specific food allergies.

February 20, 2013

A division of drug maker Mylan has distributed auto-injectors of an emergency drug used for severe allergic reactions to schools nationwide.

BASKING RIDGE, N.J. — A division of drug maker Mylan has distributed autoinjectors of an emergency drug used for severe allergic reactions to schools nationwide.

Mylan Specialty said Wednesday that since its August 2012 launch of the EpiPen4Schools program, thousands of schools around the country had elected to participate and receive free EpiPen and EpiPen Jr (epinephrine) auto-injectors. The program was launched to help schools have improved access to epinephrine in the event that a person experiences a life-threatening allergic reaction, also known as anaphylaxis.

January 29, 2013

Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

BRIDGEWATER, N.J. — Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

 

September 26, 2012

Mylan Specialty has hired a star of a popular TV series as a celebrity spokeswoman for a campaign designed to draw attention to severe allergic reactions.

BASKING RIDGE, N.J. — Mylan Specialty has hired a star of a popular TV series as a celebrity spokeswoman for a campaign designed to draw attention to severe allergic reactions.

August 14, 2012

Drug maker Mylan will pass out free EpiPen injectors to children in schools, the company said Tuesday.

BASKING RIDGE, N.J. — Drug maker Mylan will pass out free EpiPen injectors to children in schools, the company said Tuesday.

Mylan Specialty, the Mylan unit that makes the EpiPen (epinephrine), announced the launch of the EpiPen4Schools program. The program offers four free EpiPen or EpiPen Jr. injectors to public and private school students in kindergarten, elementary, middle and high school, who have valid prescriptions.

August 1, 2012

"Buy me some peanuts and Cracker Jacks," goes the line from the famous baseball anthem. For some people, however, that innocuous lyric is a ticket to the hospital, or worse.

PITTSBURGH — "Buy me some peanuts and Cracker Jacks," goes the line from the famous baseball anthem. For some people, however, that innocuous lyric is a ticket to the hospital, or worse.

May 14, 2012

A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.

BASKING RIDGE, N.J. — A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.

Mylan Specialty, a division of drug maker Mylan, said it would support various initiatives to raise awareness of life-threatening food allergies during the special week, which started Sunday and ends Saturday. Mylan Specialty is the maker of EpiPen (epinephrine), used to treat anaphylaxis, a severe allergic reaction that can occur quickly and without warning.

April 27, 2012

Two companies have settled with Teva over the latter's efforts to launch a generic version of an emergency treatment for allergic reactions.

NEW YORK — Two companies have settled with Teva over the latter's efforts to launch a generic version of an emergency treatment for allergic reactions.

Under the agreement, involving Mylan and Pfizer's Meridian Medical Technologies subsidiary, Teva will be allowed to launch a generic version of EpiPen (epinephrine) auto-injector in June 2015, assuming it wins approval from the Food and Drug Administration. Mylan Specialty markets the EpiPen, which Meridian manufactures.

February 15, 2012

Mylan is changing the name of its branded specialty pharmaceutical business, the company said Wednesday.

PITTSBURGH — Mylan is changing the name of its branded specialty pharmaceutical business, the company said Wednesday.

The drug maker announced that it would change the name of Dey Pharma to Mylan Specialty. Dey makes treatments for respiratory diseases, psychiatric disorders and severe allergic reactions, including the EpiPen (epinephrine).

August 2, 2011

The Food and Drug Administration has given tentative approval to an emergency treatment for severe allergic reactions made by Intelliject, the drug maker said.

RICHMOND, Va. — The Food and Drug Administration has given tentative approval to an emergency treatment for severe allergic reactions made by Intelliject, the drug maker said.

January 20, 2011

Mylan subsidiary Dey Pharma has launched a mobile application for patients at risk of severe allergic reactions, which is tied to its EpiPen product.

BASKING RIDGE, N.J. — Mylan subsidiary Dey Pharma has launched a mobile application for patients at risk of severe allergic reactions, which is tied to its EpiPen product.

The MyEpiPen app is available for the Apple iPhone, iPod Touch and iPad, and allows individuals, parents, guardians and others to create and share profiles of severe allergies with friends, family, teachers, school nurses, babysitters and others. Other features include an instructional video, user guide and others.

October 11, 2010

Pfizer will buy King Pharmaceuticals for $3.6 billion, Pfizer said Tuesday....

NEW YORK Pfizer will buy King Pharmaceuticals for $3.6 billion, Pfizer said Tuesday.

 

The world’s largest drug maker announced that it had agreed to acquire Bristol, Tenn.-based King for $14.25 per share, which it said was a 40% premium over the Monday closing price of King’s stock.

 

 

February 24, 2010

Mylan had profits of $93.5 million in 2009, the generic drug maker announced Thursday in...